Hainan Shuangcheng Pharmaceuticals Achieves 0.94% Return Amid Market Challenges
Hainan Shuangcheng Pharmaceuticals Co., Ltd. has emerged as a standout performer in the stock market, achieving a return of 0.94% over the past year, despite being a small-cap company in the Pharmaceuticals & Biotechnology sector. In contrast, larger firms like Chongqing Brewery Co., Ltd. and Shanghai Chengtou Holding Co., Ltd. faced declines of -0.88% and -3.39%, respectively, indicating significant challenges in the Beverages and Furniture sectors. This trend underscores the resilience of certain small-cap stocks amid broader market fluctuations, offering potential insights for investors.
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
